Vestal Point Capital, LP Uro Gen Pharma Ltd. Transaction History
Vestal Point Capital, LP
- $1.4 Trillion
- Q1 2025
A detailed history of Vestal Point Capital, LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Vestal Point Capital, LP holds 2,152,957 shares of URGN stock, worth $29 Million. This represents 1.7% of its overall portfolio holdings.
Number of Shares
2,152,957
Previous 1,630,000
32.08%
Holding current value
$29 Million
Previous $17.4 Billion
37.17%
% of portfolio
1.7%
Previous 1.03%
Shares
3 transactions
Others Institutions Holding URGN
# of Institutions
141Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$58.7 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$51.7 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$43.2 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$31 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$29.6 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $306M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...